German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients
Authors 0
- Author list not loaded yet.
Cited by 5 stored of 27
5 results
5 results